MMP9 and cancer: Thus, for the first time, differences in the levels of 20S proteasomes, ADAM10+/ADAM17-, MMP9+ and MMP9+/MMP2+/EMMPRIN+ in plasma exosomes subpopulations between CPPs and CRCPs were revealed, thereby indicating the feasibility of using them to predict cancer risk.